[Muscle relaxants in the treatment of idiopathic trigeminal neuralgia (author's transl)].
In 195 patients with idiopathic trigeminal neuralgias, atypical facial neuralgia or zoster neuralgia in the face it was shown that, in the initial stages of these diseases, the efficacy of the always satisfactory medicinal treatment with an anticonvulsant (hydantoin or carbamezathine) can be increased by combination with a muscle relaxant (especially chlormezanone). Medicinal therapy is then still frequently possible without side effects and operative treatment (Frazier-Spiller's retrogasserian neurotomy) can be postponed.
D000613:Aminobutyrates / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D002328:Carisoprodol / Q000627:therapeutic use; D002720:Chlormezanone / Q000627:therapeutic use; D002743:Chlorphenesin / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D006801:Humans; D008134:Long-Term Care; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000627:therapeutic use*; D009966:Orphenadrine / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D014277:Trigeminal Neuralgia / Q000188:drug therapy* / Q000209:etiology
D000613:Aminobutyrates; D000927:Anticonvulsants; D004338:Drug Combinations; D009125:Muscle Relaxants, Central; D011725:Pyridines; D002328:Carisoprodol; D009966:Orphenadrine; D002720:Chlormezanone; D002743:Chlorphenesin
Muskelrelaxantien zur Behandlung der idiopathischen Trigeminusneuralgie